PTEN and viral infectious disease: Some OVs are engineered to exploit specific molecular pathways in GB cells, such as mutations in protein 53 (p53) or phosphatase and tensin homolog (PTEN), which are commonly present in GB, making these cells more susceptible to viral infection and oncolysis [7, 44].